The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Venous Thromboembolism Associated With Long-Term Use of Central Venous Catheters in Cancer Patients
Abstract
Long-term central venous catheters (CVCs) have considerably improved the management of cancer patients because they facilitate chemotherapy, transfusions, parenteral nutrition, and blood sampling. However, the use of long-term CVCs, especially for chemotherapy, has been associated with the occurrence of upper-limb deep venous thrombosis (UL-DVT). The incidence of clinically overt UL-DVT related to CVCs has been reported to vary between 0.3% and 28.3%. The incidence of CVC-related UL-DVT screened by venography reportedly varies between 27% and 66%. The incidence of clinically overt pulmonary embolism (PE) in patients with CVC-related UL-DVT ranges from 15% to 25%, but an autopsy-proven PE rate of up to 50% has been reported. Vessel injury caused by the procedure of CVC insertion, venous stasis caused by the indwelling CVC, and cancer-related hypercoagulability are the main pathogenetic factors for CVC-related venous thromboembolism (VTE). Several studies have assessed the benefit of the prophylaxis of UL-DVT after CVC insertion in cancer patients. According to the results of these studies, prophylaxis with low molecular weight heparin or a low fixed dose of warfarin has been recently proposed. However, the limitations of the experimental design of the prophylactic studies do not allow definitive recommendations. The recommended therapy for UL-DVT associated with CVC is based on anticoagulant therapy with or without catheter removal. This review focuses on the epidemiology, pathogenesis, diagnosis, prevention, and treatment of VTE in cancer patients with long-term CVC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevention of Venous Thromboembolism
Geerts, W. H., Heit, J. A., Clagett, G. P., Pineo, G. F., Colwell, C. W., Anderson, F. A., & Wheeler, H. B. (2001) · Chest · doi:10.1378/chest.119.1_suppl.132s · Cited by 4,373
Preventing Complications of Central Venous Catheterization
McGee, D. C., & Gould, M. K. (2003) · New England Journal of Medicine · doi:10.1056/nejmra011883 · Cited by 2,290
The Long-Term Clinical Course of Acute Deep Venous Thrombosis
Prandoni, P., Lensing, A. W. A., Cogo, A., Cuppini, S., Villalta, S., Carta, M., Cattelan, A. M., Polistena, P., Bernardi, E., & Prins, M. H. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-1-199607010-00001 · Cited by 2,109
Meyer, G., Marjanovic, Z., Valcke, J., Lorcerie, B., Gruel, Y., Solal-Celigny, P., Le Maignan, C., Extra, J. M., Cottu, P., & Farge, D. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.15.1729 · Cited by 796
Bern, M. M., Lokich, J. J., Wallach, S. R., Bothe, A., Benotti, P. N., Arkin, C. F., Greco, F. A., Huberman, M., & Moore, C. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-76-3-112-6-423 · Cited by 788
Maki, D. G., Stolz, S. M., Wheeler, S., & Mermel, L. A. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-4-199708150-00001 · Cited by 753
Hutten, B. A., Prins, M. H., Gent, M., Ginsberg, J., Tijssen, J. G. P., & Büller, H. R. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.17.3078 · Cited by 748
Complications and Failures of Subclavian-Vein Catheterization
Mansfield, P. F., Hohn, D. C., Fornage, B. D., Gregurich, M. A., & Ota, D. M. (1994) · New England Journal of Medicine · doi:10.1056/nejm199412293312602 · Cited by 713
A modified right atrial catheter for access to the venous system in marrow transplant recipients.
Hickman, R. O., Buckner, C. D., Clift, R. A., Sanders, J. E., STEWART, P. S., & Thomas, E. D. (1979) · PubMed · Cited by 647
Ruesch, S., Walder, B., & Tramèr, M. R. (2002) · Critical Care Medicine · doi:10.1097/00003246-200202000-00031 · Cited by 629
Cited by
Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma
Palumbo, A., Rajkumar, S. V., Dimopoulos, M. A., Richardson, P. G., San Miguel, J., Barlogie, B., Harousseau, J., Zonder, J. A., Cavo, M., Zangari, M., et al. (2008) · Leukemia · doi:10.1038/sj.leu.2405062 · Cited by 840
Chopra, V., Anand, S., Hickner, A., Buist, M., Rogers, M. A., Saint, S., & Flanders, S. A. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60592-9 · Cited by 645
Cancer and venous thromboembolism
Prandoni, P., Falanga, A., & Piccioli, A. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70207-2 · Cited by 540
Assessing Risk of Venous Thromboembolism in the Patient With Cancer
Khorana, A. A., & Connolly, G. C. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.3271 · Cited by 539
Management of occlusion and thrombosis associated with long-term indwelling central venous catheters
Baskin, J. L., Pui, C.-H., Reiss, U., Wilimas, J. A., Metzger, M. L., Ribeiro, R. C., & Howard, S. C. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60220-8 · Cited by 445
Epidemiology and pathophysiology of cancer-associated thrombosis
Noble, S., & Pasi, J. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605599 · Cited by 396
Antithrombotic Therapy in Children*
Monagle, P., Chan, A., Massicotte, P., Chalmers, E., & Michelson, A. D. (2004) · Chest · doi:10.1378/chest.126.3_suppl.645s · Cited by 395
Upper-Extremity Deep Vein Thrombosis: A Prospective Registry of 592 Patients
Joffe, H. V., Kucher, N., Tapson, V. F., & Goldhaber, S. Z. (2004) · Circulation · doi:10.1161/01.cir.0000142289.94369.d7 · Cited by 384
Upper-Extremity Deep Vein Thrombosis
Joffe, H. V., & Goldhaber, S. Z. (2002) · Circulation · doi:10.1161/01.cir.0000031705.57473.1c · Cited by 373
Deep-Vein Thrombosis of the Upper Extremities
Kucher, N. (2011) · New England Journal of Medicine · doi:10.1056/nejmcp1008740 · Cited by 373
Schiffer, C. A., Mangu, P. B., Wade, J. C., Camp-Sorrell, D., Cope, D. G., El-Rayes, B. F., Gorman, M., Ligibel, J., Mansfield, P., & Levine, M. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.5733 · Cited by 368
DEBOURDEAU, P., FARGE, D., BECKERS, M., BAGLIN, C., BAUERSACHS, R. M., BRENNER, B., BRILHANTE, D., FALANGA, A., GEROTZAFIAS, G. T., HAIM, N., et al. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12071 · Cited by 316
Verso, M., Agnelli, G., Bertoglio, S., Di Somma, F. C., Paoletti, F., Ageno, W., Bazzan, M., Parise, P., Quintavalla, R., Naglieri, E., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.084 · Cited by 303
Self-citationMegestrol acetate for treatment of anorexia-cachexia syndrome
Ruiz Garcia, V., López-Briz, E., Carbonell Sanchis, R., Gonzalvez Perales, J. L., & Bort-Martí, S. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004310.pub3 · Cited by 293
Incidence, Risk Factors, and Outcomes of Catheter-Related Thrombosis in Adult Patients With Cancer
Lee, A. Y. Y., Levine, M. N., Butler, G., Webb, C., Costantini, L., Gu, C., & Julian, J. A. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.5600 · Cited by 286
Vascular Access in Oncology Patients
Gallieni, M., Pittiruti, M., & Biffi, R. (2008) · CA: A Cancer Journal for Clinicians · doi:10.3322/ca.2008.0015 · Cited by 284
S3-Leitlinie „Kolorektales Karzinom” – Aktualisierung 2008
Schmiegel, W., Reinacher-Schick, A., Arnold, D., Graeven, U., Heinemann, V, Porschen, R., Riemann, J., Rödel, C., Sauer, R., Wieser, M., et al. (2008) · Zeitschrift für Gastroenterologie · doi:10.1055/s-2008-1027726 · Cited by 274
Management of venous port systems in oncology: a review of current evidence
Vescia, S., Baumgärtner, A. K., Jacobs, V. R., Kiechle-Bahat, M., Rody, A., Loibl, S., & Harbeck, N. (2008) · Annals of Oncology · doi:10.1093/annonc/mdm272 · Cited by 264
“Moreover, an increased dose could well be associated with an increased risk of bleeding, which was not observed in this trial [45].”
Potential Regional Differences for the Tolerability Profiles of Fluoropyrimidines
Haller, D. G., Cassidy, J., Clarke, S. J., Cunningham, D., Van Cutsem, E., Hoff, P. M., Rothenberg, M. L., Saltz, L. B., Schmoll, H.-J., Allegra, C., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.2090 · Cited by 252
Young, A., Chapman, O., Connor, C., Poole, C., Rose, P., & Kakkar, A. K. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.106 · Cited by 150
Catheter-Associated Thrombosis in Patients With Malignancy
Shivakumar, S. P., Anderson, D. R., & Couban, S. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.6126 · Cited by 77
“3%.(3) Another systematic review of 16 trials including 2,169 patients found that on average, only 12% of central vein catheter-associated thrombi were symptomatic.”
Background
Metadata
- Authors
- Verso, M., & Agnelli, G.
- Venue
- Journal of Clinical Oncology
- Published
- 2003-10-01
- Volume
- 21
- Issue
- 19
- Pages
- 3665-3675
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2134617967
- Cited by
- 605
- References
- 62
- FWCI
- 14.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.